Radiation, hormone therapy improve prostate cancer survival

11/3/2011 | HealthDay News

A study of more than 1,200 men with high-risk prostate cancer found that 74% of those who received both hormone and radiation therapy were still alive after seven years compared with 66% of men under hormone therapy alone. Adding radiotherapy did not affect the overall quality of life after three years of treatment, lead researcher Padraig Warde said. The findings appear in The Lancet.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY